Parnian Kubor
Background: Cancer prevalence and the increase in its
medical care service costs especially in the end stage of
the disease, and the necessity of optimal allocation of
scarce healthcare resources altogether have resulted to
much more attention about the development and practicing
of low-cost treatments.
